Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Moreno

Showing results (251-260 of 572) with videos related to

Pageof 58
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|May 23, 2013
DNA methylation biomarkers for noninvasive diagnosis of colorectal cancerF Javier Carmona, Daniel Azuara, Antonio Berenguer-Llergo, et al.
British Journal of Cancer|March 23, 2016
A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignanciesJoaquin Mateo, David Olmos, Herlinde Dumez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 11, 2023
Sequential oral antibiotic in uncomplicated Staphylococcus aureus bacteraemia: a propensity-matched cohort analysisItziar Diego-Yagüe, Alberto Mora-Vargas, Jose Manuel Vázquez-Comendador, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2020
Development of <i>Helicobacter pylori</i> Whole-Proteome Arrays and Identification of Serologic Biomarkers for Noncardia Gastric Cancer in the MCC-Spain StudyRima Jeske, Dennis Reininger, Busra Turgu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal CancerNatalia Guillén Díaz-Maroto, Rebeca Sanz-Pamplona, Mireia Berdiel-Acer, et al.
Lupus Science & Medicine|October 25, 2022
Impact of severe infections in SLE: an observational study from the Spanish national registryVictor Moreno-Torres, María Martínez-Urbistondo, Angela Gutiérrez-Rojas, et al.
Plos One|June 4, 2010
Common variation in ISL1 confers genetic susceptibility for human congenital heart diseaseKristen N Stevens, Hakon Hakonarson, Cecilia E Kim, et al.
JCO Precision Oncology|January 27, 2022
Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung CancersAlexander Drilon, Daniel S W Tan, Ulrik N Lassen, et al.
Investigational New Drugs|March 11, 2021
Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer. Results from an expansion cohort of a phase I studyMaría Eugenia Olmedo, Martin Forster, Victor Moreno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2022
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced CancerRobert Jones, Ruth Plummer, Victor Moreno, et al.
Pageof 58

Showing results (251-260 of 572) with videos related to

Sort By:
Pageof 58
Cancer Prevention Research (Philadelphia, Pa.)|May 23, 2013
DNA methylation biomarkers for noninvasive diagnosis of colorectal cancerF Javier Carmona, Daniel Azuara, Antonio Berenguer-Llergo, et al.
British Journal of Cancer|March 23, 2016
A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignanciesJoaquin Mateo, David Olmos, Herlinde Dumez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 11, 2023
Sequential oral antibiotic in uncomplicated Staphylococcus aureus bacteraemia: a propensity-matched cohort analysisItziar Diego-Yagüe, Alberto Mora-Vargas, Jose Manuel Vázquez-Comendador, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2020
Development of <i>Helicobacter pylori</i> Whole-Proteome Arrays and Identification of Serologic Biomarkers for Noncardia Gastric Cancer in the MCC-Spain StudyRima Jeske, Dennis Reininger, Busra Turgu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal CancerNatalia Guillén Díaz-Maroto, Rebeca Sanz-Pamplona, Mireia Berdiel-Acer, et al.
Lupus Science & Medicine|October 25, 2022
Impact of severe infections in SLE: an observational study from the Spanish national registryVictor Moreno-Torres, María Martínez-Urbistondo, Angela Gutiérrez-Rojas, et al.
Plos One|June 4, 2010
Common variation in ISL1 confers genetic susceptibility for human congenital heart diseaseKristen N Stevens, Hakon Hakonarson, Cecilia E Kim, et al.
JCO Precision Oncology|January 27, 2022
Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung CancersAlexander Drilon, Daniel S W Tan, Ulrik N Lassen, et al.
Investigational New Drugs|March 11, 2021
Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer. Results from an expansion cohort of a phase I studyMaría Eugenia Olmedo, Martin Forster, Victor Moreno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2022
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced CancerRobert Jones, Ruth Plummer, Victor Moreno, et al.
Pageof 58